Document Detail

Immunological evidence for a proteolytic cleavage at the active site of antithrombin in the mechanism of inhibition of coagulation serine proteases.
MedLine Citation:
PMID:  6790279     Owner:  NLM     Status:  MEDLINE    
Previous studies have shown that a modified form of antithrombin, cleaved at a single Arg-Ser bond near the carboxy-terminal end of the chain, is formed during the reaction with thrombin concurrent with the formation of the inactive enzyme-inhibitor complex. A variety of evidence suggests that this cleavage site is the active site of antithrombin. In this work, antisera against intact antithrombin, the modified form of antithrombin and the antithrombin-thrombin complex were used in immunodiffusion analyses to probe the state of the inhibitor in its complexes with coagulation serine proteases. The results show that new antigenic determinants not present in intact antithrombin are created in modified antithrombin by the single peptide-bond cleavage. the same antigenic determinants are found also in complexes between antithrombin and thrombin or factor Xa. No evidence for the exposure of other new determinants in the complexes was obtained. The most likely conclusion from these results is that antithrombin exists in its complexes with the serine proteases as the modified, two-chain form of the inhibitor. This suggests that the mechanism of inhibition involves proteolytic cleavage of the active site of antithrombin by the protease.
P Wallgren; K Nordling; I Björk
Related Documents :
3101219 - Abnormal properties and behaviors of antithrombin iii found in a thrombophilic patient:...
8548789 - Conformational analysis of heparin epoxide: molecular mechanics computations.
8662679 - Modulation of contact system proteases by glycosaminoglycans. selective enhancement of ...
1730729 - Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced he...
8615699 - Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enha...
22105709 - App dimer formation is initiated in the endoplasmic reticulum and differs between app i...
10320809 - Characterization of the transacylase activity of rat liver 60-kda lysophospholipase-tra...
22033339 - Structural and functional characterization of α-isopropylmalate synthase and citramalat...
9708979 - Role of a dynamic loop in cation activation and allosteric regulation of recombinant po...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of biochemistry / FEBS     Volume:  116     ISSN:  0014-2956     ISO Abbreviation:  Eur. J. Biochem.     Publication Date:  1981 Jun 
Date Detail:
Created Date:  1981-10-29     Completed Date:  1981-10-29     Revised Date:  2007-07-23    
Medline Journal Info:
Nlm Unique ID:  0107600     Medline TA:  Eur J Biochem     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  493-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Binding Sites
Immune Sera
Protease Inhibitors*
Protein Binding
Serine Endopeptidases
Thrombin / metabolism
Reg. No./Substance:
0/Antithrombins; 0/Immune Sera; 0/Protease Inhibitors; EC 3.4.21.-/Serine Endopeptidases; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Characteristics of the calcium-mediated mechanism activating adenylate cyclase in Trypanosoma brucei...
Next Document:  The mechanism of uncoupling by picrate in Escherichia coli K-12 membrane systems.